Projects per year
Personal profile
Biography
Prof Anneke van der Walt is an academic Neurologist with subspecialty training in multiple sclerosis, neuroimmunology and neuro-ophthalmology. She leads the MS and Neuro-ophthalmology Research Group at the School of Translational Medicine, Monash University, and serves as Director of the MS, Neuroimmunology and Neuro-ophthalmology Unit at Bayside Health/Alfred Care Group.
Prof van der Walt completed her undergraduate training in South Africa before relocating to Australia, where she completed specialist training in Neurology and a PhD in Neuroscience under the supervision of Professors Trevor Kilpatrick and Helmut Butzkueven at the University of Melbourne. This was followed by postdoctoral training at the Melbourne Brain Centre, UoM (2013 to 2017).
Prof van der Walt is Chief Operating Officer of the MSBase Foundation, overseeing a registry of over 140,000 patient records across 40 countries, and serves on the executive committee of the BigMS collaboration (>300,000 records). She holds editorial roles at the Multiple Sclerosis Journal (Q1, IF 5.2) and serves as a Lead Correspondent for the ECTRIMS Controversies Podcast. She has delivered over 60 invited lectures and 8 keynote addresses internationally.
She has received substantial competitive fellowship and grant funding totalling over $34 million, with $17 million secured as CIA/CI from competitive bodies including two NHMRC fellowships.
With an H-index of 42 and over 5,000 citations, 69% of her publications appear in top-quartile journals.
Research interests
Prof. Van der Walt's research program spans five interconnected areas: ageing in MS, digital and neuroimaging biomarkers, women's health in MS, real-world evidence from disease-modifying therapies, and neuro-ophthalmology. She co-developed MSReactor, a digital cognitive monitoring platform and leads Australia's only multidisciplinary Idiopathic Intracranial Hypertension clinic.
A/Prof van der Walt is also the Chief Operating Officer of the MSBae Foundation. Her clinical roles include appointments as the Head, MSNI Unit and Neuro-ophthalmology Service at Alfred Health, Melbourne.
Supervision interests
Prof van der Walt has supervised 20 PhD students (11 to completion) and currently supervises 9 PhD candidates and 3 postdoctoral researchers.
Monash teaching commitment
2019
- TRM006 Translational Neuroscience Masters Degree. Seminar: Assessment of the anterior visual system and role in translation in multiple sclerosis.
2018
- Teaching of 3rd year medical students, CCS, Monash University.
Education/Academic qualification
PhD, University of Melbourne
2 Feb 2008 → 31 Oct 2012
Bachelor of Medicine and Surgery (MBChB), University of Pretoria
31 Jan 1993 → 30 Nov 1998
External positions
Clinical Associate Professor, University of Melbourne
30 Nov 2017 → …
Honorary Research Fellow, Bionics Institute of Australia (trading as Bionics Institute)
1 Feb 2015 → …
Consultant Neuroophthalmologist, Royal Victorian Eye & Ear Hospital (RVEEH)
1 Feb 2008 → …
Research area keywords
- Neuroscience
- Multiple Sclerosis (MS)
- Optic neuritis
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 5 Gender Equality
-
SDG 16 Peace, Justice and Strong Institutions
Collaborations and top research areas from the last five years
-
A Phase III randomised, placebo-controlled, double-blind, multi-centre, clinical trial to determine the efficacy and safety of Presendin in idiopathic intracranial hypertension
Van Der Walt, A. (Primary Chief Investigator (PCI))
17/02/23 → 17/02/25
Project: Research
-
VALUE-Ig : eVidence synthesis to inform the optimAL UsE of Immunoglobulin
Petrie, D. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Harris, A. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Irving, A. (Chief Investigator (CI)), Van Der Walt, A. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Fanning, L. (Chief Investigator (CI)), Spencer, A. (Chief Investigator (CI)), Hawkes, E. (Chief Investigator (CI)) & Crispin, P. (Chief Investigator (CI))
1/04/22 → 31/03/27
Project: Research
-
Active monitoring of cognitive function to detect preclinical changes and define longitudinal cognitive trajectories in people with multiple sclerosis
Merlo, D. (Primary Chief Investigator (PCI)) & Van Der Walt, A. (Supervisor)
1/01/22 → 31/12/24
Project: Research
-
Determining the risk of cervical precancer and cancer in women with multiple sclerosis: a national data linkage study.
Van Der Walt, A. (Primary Chief Investigator (PCI)), Jokubaitis, V. (Chief Investigator (CI)), Butzkueven, H. (Chief Investigator (CI)), Taylor, B. V. (Chief Investigator (CI)), Lechner-Scott, J. (Chief Investigator (CI)) & Brotherton, J. M. L. (Chief Investigator (CI))
1/01/22 → 30/06/27
Project: Research
-
Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria
Oh, J., Barkhof, F., Bar-Or, A., Ciccarrelli, O., Coetzee, T., Filippi, M., Granziera, C., Hacohen, Y., Hemmer, B., Kantarci, O. H., Kim, H. J., Lebrun-Frenay, C., Montalban, X., Mowry, E., Ontaneda, D., Prat, A., Reich, D. S., Rovira, À., Sati, P. & Siva, A. & 9 others, , 2026, (Accepted/In press) In: Nature Medicine. 5 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
-
Corrigendum to “Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study” [Multiple Sclerosis and Related Disorders Vol 106; Feb 2026; Article Number 106885] (Multiple Sclerosis and Related Disorders (2026) 106, (S2211034825006236), (10.1016/j.msard.2025.106885))
Butzkueven, H., Farr, P., Ozakbas, S., Boz, C., Kalincik, T., Taylor, L., Van Der Walt, A., Alroughani, R., Buzzard, K., Skibina, O., Lechner-Scott, J., Laureys, G., Terzi, M., Van Pesch, V., Grand-Maison, F., Barnett, M., Kermode, A., Menoyo, J. L. S., Rojas, J. & Willekens, B. & 6 others, , May 2026, In: Multiple Sclerosis and Related Disorders. 109, 2 p., 107131.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
Formative research in the codesign of a discrete choice experiment with patients with myasthenia gravis: selecting and refining attributes, levels and scenarios
Aydin, G., Zhang, X., Petrie, D., Van der Walt, A., Reddel, S., Buzzard, K., Windle, N., White, S., Bergin, C. & Fanning, L., 2026, In: The Patient - Patient-Centered Outcomes Research. 19, p. 435-448 14 p.Research output: Contribution to journal › Article › Research › peer-review
-
Multiple sclerosis controversies: Detecting progressing events in MS clinics in real-time is possible-commentary
van der Walt, A., May 2026, In: Multiple Sclerosis Journal. 32, 6, p. 572-573 2 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
Population-representative brain templates and morphometric aging signatures from ultra-low-field (64 mT) MRI
Islam, K. T., Zakavi, P., Zhong, S., Dayarathna, S., Peiris, H., Kavnoudias, H., Foong, Y. C., Van Der Walt, A., Domínguez, J., Caeyensberghs, K., Egan, G. F., Law, M. & Chen, Z., 13 May 2026, p. 1-4. 4 p.Research output: Contribution to conference › Abstract › peer-review
Prizes
-
-
MS Australia President’s Medal
Van Der Walt, A. (Recipient), 2022
Prize: Prize (including medals and awards)
-
-
-
-
Leveraging real-world evidence to inform outcomes in MS: Novartis-sponsored seminar
Van Der Walt, A. (Contributor)
2023 → …Activity: Community Talks, Presentations, Exhibitions and Events › Public event
-
Neuroimmunology and MS updates. National Webinar
Van Der Walt, A. (Contributor)
2022Activity: Community Talks, Presentations, Exhibitions and Events › Public event
-
PACTMAN, PACTRIMS. Symptomatic treatment of MS
Van Der Walt, A. (Contributor)
2022Activity: Community Talks, Presentations, Exhibitions and Events › Public event
-
Neuroimmunology Society Meeting, Newcastle Australia. Cervical dysplasia as a long-term complication of MS therapies
Van Der Walt, A. (Contributor)
2021Activity: Community Talks, Presentations, Exhibitions and Events › Public event
-
PACTRIMS conference, 2021. Real world experience with Cladribine: results from the MSBase Registry
Van Der Walt, A. (Contributor)
2021Activity: Community Talks, Presentations, Exhibitions and Events › Public event